Adam is an Executive Director and External Accelerator Lead at Pfizer where he creates protactive partnerships and business development deals to build value for Pfizer’s portfolio. He has more than 28 years experience working in biopharma and recently led Pfizer’s Design and Synthesis Sciences platform medicinal chemistry group which successfully delivered targeted covalent inhibitors, protein homeostasis modulators and vaccine antigens to Pfizer’s clinical portfolio. Adam holds a Ph.D. in Organic Chemistry from Columbia University.
Speaking In
1:00 PM - 2:00 PM
Monday, June 5
